Hubei Biocause Heilen Pharmaceutical , Ltd. Inventory

Hubei Biocause Heilen Pharmaceutical , Ltd. (301211.SZ) currently reports a inventory of $140M as of June 2026. That compares with $120M in the prior-year period — up 20.2% year over year. Use the charts on this page to explore Hubei Biocause Heilen Pharmaceutical , Ltd.'s inventory history and peer comparisons.

Hubei Biocause Heilen Pharmaceutical , Ltd.'s inventory increased from $120M to $140M — a 20.2% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Hubei Biocause Heilen Pharmaceutical , Ltd. reported $140M in inventory as of June 2026. That compares with $120M in the prior-year period — up 20.2% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current inventory of $140M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Hubei Biocause Heilen Pharmaceutical , Ltd., and consider following 301211.SZ for alerts when major investors trade the stock.